INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2002

Phlebotomy in patients with high-ferritin type 2 diabetes improved insulin sensitivity and reduced HbA1c levels compared with observation.

Patients with high-ferritin type 2 diabetes were randomized to blood letting (three 500-ml phlebotomies at 2-week intervals) or observation, with outcomes evaluated at baseline, 4 months, and 12 months. Blood HbA1c decreased significantly only in the blood-letting group at 4 months (mean difference, -0.61; 95% CI, -0.17 to -1.048; P = 0.01). Changes in insulin sensitivity differed significantly between groups at 4 months (80.6 +/- 43.2% vs. -8.6 +/- 9.9%, P = 0.049) and at 12 months (55.5 +/- 24.8% vs. -26.8 +/- 9.9%, P = 0.005). AUC C-peptide decreased by -10.2 +/- 6.3% after blood letting and increased by 10.4 +/- 6.4% in controls at 4 months (P = 0.032), returning to baseline levels in both groups at 12 months.

Study type
Randomized controlled trial
Who was studied
Patients with high-ferritin type 2 diabetes negative for the C282Y mutation
What was measured
Insulin sensitivity, insulin secretion (AUC C-peptide), and glycated hemoglobin (HbA1c)

THE PAPER

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.

Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Diabetes, 2002.

PubMed 11916918 ↗DOI 10.2337/diabetes.51.4.1000 ↗

Diabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.